Oral BTK Inhibitor Shows Disability Benefit in Progressive Multiple Sclerosis Trial

• February 17, 2026

Inflammatory CADASIL: the cross-link between CADASIL and multiple sclerosis: a report of two cases and systematic review of the literature

• by Ali Mahmoud Ahmed, Niraj Mistry, Ahmed Samir Gehad, Abdelmonem M. Hassan

• June 5, 2026

Partial sensory rhizotomy in therapy-refractory and recurrent trigeminal neuralgia – a single center experience

• by Ina Lange, Ehab El Refaee, Marc Matthes, Henry W. S. Schroeder, Jörg Baldauf

• February 18, 2026

Top 10 Evidence-Based Essentials in Neurology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice.

• by mdspire news news staff

• July 9, 2026

• 3 min